BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 2849045)

  • 1. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
    Walker MW; Miller RJ
    Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.
    Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Inoue T; Oya M; Baba S
    Endocrinology; 1990 Aug; 127(2):934-41. PubMed ID: 2164925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
    Chatterjee TK; Fisher RA
    Mol Pharmacol; 1991 Jun; 39(6):798-804. PubMed ID: 1646951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes.
    Balasubramaniam A; Sheriff S; Rigel DF; Fischer JE
    Peptides; 1990; 11(3):545-50. PubMed ID: 2166278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y receptor binding sites in rat brain: differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity.
    Lynch DR; Walker MW; Miller RJ; Snyder SH
    J Neurosci; 1989 Aug; 9(8):2607-19. PubMed ID: 2549216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
    Presky DH; Schonbrunn A
    Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of peptide YY receptors in the brain.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Shii K; Yokono K; Mizuno N; Baba S
    Endocrinology; 1989 Jan; 124(1):402-9. PubMed ID: 2535812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
    Krause J; Eva C; Seeburg PH; Sprengel R
    Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.
    Dumont Y; Fournier A; St-Pierre S; Quirion R
    J Pharmacol Exp Ther; 1995 Feb; 272(2):673-80. PubMed ID: 7853181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neuropeptide Y receptors in rabbit kidney: preliminary comparisons with rat and human kidney.
    Schachter M; Miles CM; Leys K; Sever PS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S157-62. PubMed ID: 2455171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
    Laburthe M; Chenut B; Rouyer-Fessard C; Tatemoto K; Couvineau A; Servin A; Amiranoff B
    Endocrinology; 1986 May; 118(5):1910-7. PubMed ID: 3009142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
    Singh G; Singh L; Raufman JP
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
    Gehlert DR; Gackenheimer SL; Schober DA
    Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis.
    Voisin T; Rouyer-Fessard C; Laburthe M
    Am J Physiol; 1990 May; 258(5 Pt 1):G753-9. PubMed ID: 2159240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
    Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.